Cow's milk protein Intolerance - DSMIG

0 downloads 0 Views 4MB Size Report
Medicine. Publications: •Lipid profile of children's in high risk family – Best ... Scientific Study of Intellectual Disabilities (IASSID)). Books: "With love from Babli - A .... assistance/hospitalization for respiratory complications after CMP free diet.
Effect of CMPI (Cow’s milk protein Intolerance) and recurrent respiratory infections in children with Down’s syndrome

Dr. Priya Chandrasekhar

MBBS, DNB,

MNAMS

INDIRA CHILD CARE CENTER CHENNAI, INDIA

Dr. Priya Chandrasekhar Principal Investigator 

Consultant in Pediatrics Medicine and Adolescent health Indira Child Care Center & Apollo Hospitals Group

  

National Instructor for PALS (Pediatric Advanced Life Support) by American Heart Association in India Fellow of Royal society of Medicine – UK Member National Academy of Medical Sciences

Accolades: • Dr. James Flett Endowment Award - Social and Preventive Pediatrics (2000) • Maitlander Memorial Prize for surgery • Dr. B. Ramamurthy Gold Medal for Neurology, Neurosurgery & Publications: Medicine •Lipid profile of children's in high risk family – Best Paper award Indian journal of Pediatrics (2000)

Dr. Surekha Ramachandran Co-Investigator Accolades 

Co-Founder and Chairperson of the Down's Syndrome Federation of India (Tamilnadu Chapter)



PhD in Cognitive Deficit and Depression in Down Syndrome



Promoter of Mathru Mandir, Chennai



Board Member of Down Syndrome International (DSi)



"Woman of the Year" Award in 1998 "For the sake of honor" award (International Association for the Scientific Study of Intellectual Disabilities (IASSID))

Books: 

"With love from Babli - A child with Down's Syndrome" – (A Referral Guide)



"Life starts at Sixteen - Down's Syndrome“



"Positive approach to Down Syndrome - Guide for Down Syndrome children”

What is CMPI ? 

Non-immunological reactions against cow’s milk protein are defined as cow's milk protein intolerance (CMPI)



Cow's milk protein intolerance (CMPI), are reproducible adverse reactions to cow's milk protein(s) and may be due to the interaction between one or more milk proteins.

World Incidence of CMPI 3 - 7.5% of babies are allergic to cow's milk in the world (Host A et.al)  Very few studies confirm the prevalence of CMPI in India (Poddar U et.al)  To our knowledge there is no exclusive study conducted for DS children with CMPI and respiratory complications 

Signs and Symptoms Diarrhe a

Asthm a

Vomit

Colic

Skin Rash Eczema

Wheezing and Coughing

Allergy – Short Primer Top ‘5’ Food Allergens

 Cow’s

Milk  Tree nuts  Peanuts  Wheat  Eggs

Historical records of food allergy Ca. 400 BC Hippocrates Comment on Cheese: ….but there are some who do not bear it well, their constitutions are different…..

1908 Dr. Alfred Schofield successfully treated a boy who suffered from angioedema and asthma because of an allergy to eggs

Conclusion: Food allergies can cause illness, disease and poor health

Geographical Location

Chennai

Rationale of the Study Down’s syndrome is a disorder unattended by the various health authorities more specifically in developing countries.  The healthcare program for children with Down’s syndrome (DS) is of least priority.  Recurrent respiratory infections are common in children with DS 

Rationale of the Study To study the frequency of antibiotics used for recurrent infections  To demarcate between allergy induced respiratory complications and infection related  To study the effect of quality of life in DS children 

Causes of Respiratory disorders Normal Children 1. Infectious diseases 2. Allergy

Down Syndrome 1. Infectious diseases 2. Allergy 3. Genetic Conditions 4. Abnormal immune responses 5. Accelerated ageing 6. Oxidative Stress 7. Micro aspiration (due to deranged anatomy)

Prevalence 

The prevalence of Down’s syndrome in Indian sub continent slightly varies from global data (1 in 750 live births)(BDRI, Chennai-India).

Exact prevalence was impossible to collect from Indian sub continent as there is a lack of central registry for DS and other Intellectual and genetic disorders.  South East Asia Regional Neonatal Prenatal Database (SEAR-NPD) 2010 reported 0.05% (n=1948) of Down syndrome cases in India 

Published sources of DS in India S.No Prevalence of Year DS 1 1.17 in 1000 or 1985 1 in 853 2 0.81 in 1000 1998

Location

Project

Hyderabad

Source Isaac et al. 1985

Delhi

SOMDI*

Verma et al. 1998

3

1.04 in 1000

1998

Baroda

SOMDI*

Modi et al. 1998

4

1 in 1510

1998

Bombay

SOMDI*

Barucha 1998

* Study of malformations and Down’s syndrome in India

Why DS study 

Children with DS are predisposed to following health conditions transcending various systems. ◦ ◦ ◦ ◦ ◦ ◦ ◦

Endocrine (Yousra Hawli et al., 2009) Cardiovascular (Vis et.al 2009, Bhatia 1991) Respiratory (Pandit et.al 2011) Immune (Nespoli et. al 1993, Pueschel et. al 1990) Gastro intestinal (Pueschel et. al 1990) Obesity (Melville et al 2005) Musculo skeletal (Caide MS et al 2006, Mik G et al 2008) ◦ Hematological systems (Lang B 2000)

Hospitalization and DS 

A population cohort study - children with intellectual disability had ◦ hospital admission on more occasions ◦ longer hospitalization ◦ larger range of clinical diagnosis



This study also revealed that children with DS comprise 40% of the total population in the study ◦ (Williams et al 2005)



Increased hospitalization of DS children is consistent across the globe and more references are point towards respiratory disorders ◦ (So SA et.al. 2007, Bloemers BL et.al 2010).

Respiratory tract infections in DS children RTI in DS is caused by diverse pathologic origin e.g. viruses, bacteria, fungi or combination.  Frequency of URTI is (12% have more than 3 URTI in 12 months) increased compared to healthy controls. 

Recurrent Respiratory infection (includes any one of..)  ≥ 6 respiratory infections per annum,  ≥ 1 respiratory infections per month involving the upper airways from September to April,  ≥ 3 respiratory infections per annum involving the lower airways. (Gruppo di Studio di Immunologia della Societá Italiana di

RTI in DS children Upper Respiratory Tract infections (URTI)  URTI may be due to abnormal anatomy of respiratory tract in DS individuals ◦ Hypoplasia of nose and sinuses ◦ Midface hypoplasia with small nasal area and sinuses. Lower Respiratory Tract infections (LRTI)  LRTI is the major cause of hospitalization leading to pulmonary complication and intensive medical care  Acute lung injury may be attributed to elevated rate of apoptosis of leucocytes, epithelial cells or granulocytes.

Study Plan Title

Effect of CMPI (Cow’s milk protein Intolerance) and respiratory infections on children with Down’s syndrome

Study Duration

12 months

Study Center(s) Single-center

Objectives

Primary Objective To observe the effect of CMPI in relation with recurrent respiratory infection in DS children Secondary Objective  Effect of removing cow’s milk protein and follow-up of incidence of respiratory infection

Diagnosis and Main Inclusion Criteria

Children with DS, positive for CMP antibody usually IgE mediated

Study Design

Quasi experimental

Study End Points Primary Endpoint  To study the change from baseline in dependence of medical assistance/hospitalization for respiratory complications after CMP free diet Secondary Study Endpoints  Effect of removing cow’s milk protein and follow-up of incidence of respiratory infection

Study End Points Exploratory Endpoints  To observe the QOL* parameters from Parents perspective during the study and thereafter

* QOL - Quality of Life

Study Population Population

No

Comments

Total Screened

108

Screen failed

2

Had major illness

Lost to follow

3

Moved to other state

Refused blood test

3

Non compliant

Study Population

100

Subject Selection Children (1 – 10 years)with DS, confirmed by Karyotyping or genetic analysis  Children dependent on cow’s milk  The patient is in satisfactory health  Informed consent obtained from legal parents  The patient and parents are willing and able to comply with scheduled visits and tests 

Diet intervention Screened children were advised to stop cow’s milk and use alternative products.  Few alternatives to cow’s milk 

Soy milk formula (Isomil, Nusobee and Prosobee)

Partially Hydrolyzed Formulas (Gentlease and Good Start Supreme) Extensively Hydrolyzed Formulas (Nutramigen Lipil, Pregestimil and Alimentum) Free Amino Acid Formulas (Neocate and Elecare)

Exclusion Criteria DS Children with Cardiac complications  Children not cooperative for blood collection and routine tests  Children with acute malignancy 

Early Withdrawal of Subjects Children requiring hospitalization for respiratory condition.  Safety reasons at the discretion of the Principal Investigator.  Failure of subject to adhere to protocol requirements.  Withdrawal of consent for study. 

Ethics To conform with International and National regulations for Research on humans  Adherence with ICMR (Indian Council of Medical Research) Guidelines for research on human  “Ethical Down syndrome research” 

Ethics 

Name of the EC: National Ethics Committee Chennai, India



Reg No: US-OHRP – IORG0006162



List of Documents approved ◦ Protocol v. 1.1 ◦ Parental permission/ Research Informed Consent (Bilingual – English and Tamil) v 1.1 ◦ Case Report Form

Ethics 

Name of the EC: National Ethics Committee Chennai, India



Reg No: US-OHRP – IORG0006162



List of Documents approved ◦ Protocol v. 1.1 ◦ Parental permission/ Research Informed Consent (Bilingual – English and Tamil) v 1.1 ◦ Case Report Form

Study Procedures Activity

Screening

End of Study

Medical history





Vitals













Blood Collection

Questionnaire Administration

Monthly questionnaire administration and vitals for 9 months

Medical history 

Medical history



Complete physical examination



Screening for inclusion criteria of the protocol

Consent Ethics committee approved version of the Informed Consent Form (ICF) was given to parent for perusal  Detailed Study procedure explained including schedule for blood tests  Consent was obtained after clarification session  Bi-lingual versions (English and Tamil) were used 

Past medical history ◦ ◦ ◦ ◦ ◦

Major illness Respiratory illness Antibiotic regimen Use of paracetamol and anti-histamines Hospitalization, treated for infections, respiratory problems

Vitals Baseline vitals recorded  Considerations for dietary habits of DS children  Overall health status  Vaccination history chart  Growth chart was reviewed 

Hematology 

Milk: Allergen Specific IgE ◦ Chemiluminescence/ ImmunoCAP

Total IgE, Serum  Hemoglobin, Hemocrit  Total Leukocyte count  Differential count Central Lab: SRL – Super Religare Laboratories Ltd., (CAP- College of American Pathologist and NABL approved Laboratory) 

Research Tools 

Informed Consent Forms (version 1.1) (Bi-Lingual – English and Tamil)



Questionnaire (version 1.1) (Bi-Lingual – English and Tamil)

Data Collection Sheet for monthly assessments (version 1.0)  Patient record for other medical illness during the study 

ICF - English

ICF - Tamil

Questionnaire

Data Analysis Primary Endpoint  To study the change from baseline in dependence of medical assistance/hospitalization for respiratory complications after CMP free diet Secondary Study Endpoints  To observe the change in the clinical presentation before and after CMP free diet

Statistical Analysis Statistical analyses were done using SPSS v. 17 (Chicago, IL, USA)  Chi-Square was used to analyze the significant difference between proportions  Variables were analyzed as categorical or continuous  Mc-Namer test was used for categorical data  Proportional analysis were also used for analysis  Statistical results were presented 

Results        

Demographic CMPI incidence Hemoglobin level Haematocrit level WBC / Lymphocytes level Total IgE level Cough before and after advised diet Interventions before and after advised diet Following slides graphically summarizes the clinical findings in the DS children

Age distribution in CMPI positive and negative group Age group (years)

CMPI positive

CMPI negative

Total (%)

0.5 – 3 3.1 – 6 6.1 – 10

7 (21.2%) 12 (33.3%) 12 (38.7%)

26 (78.8%) 24 (66.7%) 19 (61.3%)

33 36 31

Total

31

69

100

Age distribution in CMPI positive and negative group 78.8 80 66.7 61.3

70

Frequency in {ercentage

60

50

38.7

Negative

33.3 40

Positive

30

21.2

20

10

0 0.5 - 3

3.1 - 6

6.1 - 10

Incidence of Cow Milk Protein Intolerance (Allergen) Cow milk protein allergen

Total

Allergen Positive

Negative

Positive

31 (100.0%)

0 (0.0%)

31

Negative

0 (0.0%)

69 (100.0%)

69

Total

31

69

100

Chi square = 100; p value = 0.000 From the above table we have arrived the comparison between cow milk protein allergen among groups. We’ve also arrived significant difference (since p< 0.05) by applying chi square test and we conclude that the above said variables are associated (i.e dependant each other)

Incidence of Cow Milk Protein Intolerance (Allergen) 69

70

Frequency in Percentage

60

50 31 40

30

20

10

0 CMPI Positive

CMPI Negative

Hemoglobin With Cow milk protein allergen Cow milk protein allergen

Total

Total Hb Positive

Negative

Normal

15 (30.6%)

34 (69.4%)

49

Abnormal positive

14 (28.6%)

35 (71.4%)

49

Abnormal negative

2 (100.0%)

0 (0.0%)

2

Total

31

69

100

Chi square = 4.59; p value = 0.10 From the above table we have arrived the comparison between cow milk allergen and hemoglobin. We’ve also arrived insignificant difference (since p> 0.05) by applying chi square test and we conclude that the above said variables are not associated (i.e. independent each on other)

Haematocrit (PCV) levels in study population Cow milk protein allergen

Total

PCV Positive

Negative

Normal

24 (26.9%)

57 (70.4 %)

81

Abnormal

7 (36.8%)

12 (44.4%)

19

Total

31

69

100

Chi square = 0.374; p value = 0.541 From the above table we have arrived the comparison between cow milk allergen and total IgE We’ve also arrived insignificant difference (since p> 0.05) by applying chi square test and we conclude that the above said variables are not associated (i.e. independent on each other)

White blood cells with Cow milk protein allergen Cow milk protein allergen

WBC

Total Positive

Negative

Normal

26 (28.6%)

65 (71.4 %)

91

Abnormal

5 (55.6%)

4 (44.4%)

9

Total

31

69

100

Chi square = 2.788; p value = 0.095 Chi square = 4.59; p value = 0.10 From the above table we have arrived the comparison between cow milk allergen and WBC. We’ve also arrived insignificant difference (since p> 0.05) by applying chi square test and we conclude that the above said variables are not associated (i.e. independent each on other)

WBC count

Lymphocytes

Total IGE with Cow milk protein allergen Cow milk protein allergen

Total

Total IgE Positive

Negative

Normal

12 (20.8%)

64 (84.2%)

76

Abnormal

19 (79.2%)

5 (15.8%)

24

Total

31

69

100

Chi square = 34.252; p value = 0.000 From the above table we have arrived the comparison between cow milk protein allergen and total IgE. We’ve also arrived significant difference (since p< 0.05) by applying chi square test and we conclude that the above said variables are associated (i.e. dependant on each other)

Total IgE levels in study population

Cough before and after advised diet Pre and Post condition of cough among Cow milk protein allergen (Positive / Negative) cases Cough after advised diet

Cow milk protein allergen

Positive

Negative

Cough before Dry advised diet With Expectoration Total Pre study condition

Dry With Expectoration

Total

No cough 1 (100)

Dry 0

16 (53.3) 17

13 (43.3) 13

1 (3.4) 1

30

12 (19.4) 0

50 (80.6) 1 (14.3) 51

0

62

6 (85.7) 6

7

12

With expectoration Total 0 1

31

69

There is highly statistical significant difference (p